Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03432325 · ClinicalTrials.gov registry record · NA
Neural Enabled Prosthesis for Upper Limb Amputees
A NA study of Prosthesis User and Amputation Arm and Hand, Unilateral Right, sponsored by University of Arkansas, Fayetteville.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 2
- Study locations
NCT03432325: Recruiting NA study of Prosthesis User and Amputation Arm and Hand, Unilateral Right, sponsored by University of Arkansas, Fayetteville.
NCT03432325 is a NA study of Prosthesis User and Amputation Arm and Hand, Unilateral Right that is actively recruiting participants, run by University of Arkansas, Fayetteville. The registered enrollment target is 15 participants, below the 56-participant average among 12 other Prosthesis User trials with a reported enrollment target (73% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03432325, a NA study of Prosthesis User and Amputation Arm and Hand, Unilateral Right, is actively recruiting participants, sponsored by University of Arkansas, Fayetteville.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is designed to evaluate the feasibility of The Adaptive Neural Systems Neural-Enabled Prosthetic Hand (ANS-NEPH) system.
Primary Outcome
Documented as the number of treatment-related adverse events as assessed by CTCAE v4.0.
Conditions Studied
Interventions
- DEVICE Neural Enabled Prosthesis
Study Locations (2)
Arkansas
- University of Arkansas - Fayetteville
Maryland
- Walter Reed National Military Medical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2017-12-14 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What NCT03432325 shows while recruiting
NCT03432325 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 56-participant average among 12 other Prosthesis User trials with a reported enrollment target (73% lower).
The record links to 3 conditions, with Prosthesis User appearing as the primary indexed condition, and to 1 intervention - of which Neural Enabled Prosthesis is the first listed.
NCT03432325 reports a single indexed study location in Arkansas, Maryland.
Frequently Asked Questions
What is clinical trial NCT03432325 about?
NCT03432325 is a clinical study titled "Neural Enabled Prosthesis for Upper Limb Amputees". This study is designed to evaluate the feasibility of The Adaptive Neural Systems Neural-Enabled Prosthetic Hand (ANS-NEPH) system.
What is the current status of trial NCT03432325?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2017-12-14. Estimated completion is 2025-12-31.
What conditions does trial NCT03432325 study?
This clinical trial studies the following conditions: Prosthesis User, Amputation Arm and Hand, Unilateral Right, Amputation Arm and Hand, Unilateral Left.
What interventions are being tested in trial NCT03432325?
The interventions under investigation include: Neural Enabled Prosthesis (DEVICE).
Who is sponsoring clinical trial NCT03432325?
This trial is sponsored by University of Arkansas, Fayetteville, which has 25 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03432325 being conducted?
This trial has 2 study locations across Arkansas, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prosthesis User
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03432325's enrollment target sits among peer trials
15 9th of 12 higher than 4 of 12 other Prosthesis User trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prosthesis User trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Outcomes With Non-Powered vs. Powered Prosthetic Knees by K2-level Amputees
RECRUITING · NA
-
Effects of Myoelectric Channel Count and Targeting for Upper Limb Prosthetic Control
RECRUITING · NA
-
Effects of Microprocessor-controlled Prosthetic Knees on Fall-related Health Outcomes in Limited Community Ambulators
RECRUITING · NA
-
Caesar Foot Take-Home Validation Testing
RECRUITING · NA
-
Optimizing Prosthetic Prescription to Mitigate the Effects of Perspiration
ACTIVE NOT RECRUITING · NA
-
Transfemoral Powered Foot and Physical Therapy Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI